ChemoCentryx Announces Results of FDA Advisory Committee Meeting on Avacopan in ANCA-Associated Vasculitis
Go back to ChemoCentryx Announces Results of FDA Advisory Committee Meeting on Avacopan in ANCA-Associated Vasculitis| CHEMOCENTRYX (NASDAQ: CCXI) | Delayed: 10.44 +0.07 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.37 | 52 Week High | $8.30 | |||
| Open | $10.44 | 52 Week Low | $1.92 | |||
| Day High | $10.44 | P/E | N/A | |||
| Day Low | $10.40 | EPS | $-1.00 | |||
| Volume | 5,324 | |||||
